200 related articles for article (PubMed ID: 21586213)
1. Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Bae S; Allanore Y; Coustet B; Maranian P; Khanna D
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S15-21. PubMed ID: 21586213
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.
Gualtierotti R; Ingegnoli F; Two R; Meroni PL; Khanna D; Adorni G; Becciolini A; Ciavarella T; Marfia G; Murgo A; Scalone L; Ughi N; Zeni S;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S55-60. PubMed ID: 26339890
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Khanna D; Hays RD; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Fathi N; Bechtel A; Furst DE
Arthritis Rheum; 2009 Sep; 61(9):1257-63. PubMed ID: 19714600
[TBL] [Abstract][Full Text] [Related]
4. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.
Zekovic A; Damjanov N
Rheumatol Int; 2017 May; 37(5):735-741. PubMed ID: 28271157
[TBL] [Abstract][Full Text] [Related]
5. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
[TBL] [Abstract][Full Text] [Related]
6. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.
Taş YM; Derviş Hakim G; Keskinoğlu P; Kenar G; Yarkan H; Zengin B; Can G; Önen F; Akkoç N; Birlik M; Akarsu M
Turk J Gastroenterol; 2019 Mar; 30(3):234-241. PubMed ID: 30541712
[TBL] [Abstract][Full Text] [Related]
7. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.
Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE
Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173
[TBL] [Abstract][Full Text] [Related]
8. A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Gorga M; Mihai C; Soare AM; Dobrotă R; Gherghe AM; Stoica V
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S61-7. PubMed ID: 26316302
[TBL] [Abstract][Full Text] [Related]
9. Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort.
Low AHL; Xin X; Law WG; Teng GG; Santosa A; Lim A; Chan G; Ng SC; Thumboo J
Clin Rheumatol; 2017 Jul; 36(7):1643-1648. PubMed ID: 28058539
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis.
Lee TH; Lee JS; Park S; Lee KA; Kim HS
Korean J Intern Med; 2021 Nov; 36(6):1504-1514. PubMed ID: 33561335
[TBL] [Abstract][Full Text] [Related]
11. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
Bodukam V; Hays RD; Maranian P; Furst DE; Seibold JR; Impens A; Mayes MD; Clements PJ; Khanna D
Rheumatology (Oxford); 2011 Feb; 50(2):330-4. PubMed ID: 20884655
[TBL] [Abstract][Full Text] [Related]
12. Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Khanna D; Furst DE; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Hays RD
J Rheumatol; 2011 Sep; 38(9):1920-4. PubMed ID: 21724699
[TBL] [Abstract][Full Text] [Related]
13. Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Ferreira PL; Genrinho I; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674306
[TBL] [Abstract][Full Text] [Related]
14. Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.
Frech TM; Khanna D; Maranian P; Frech EJ; Sawitzke AD; Murtaugh MA
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S22-5. PubMed ID: 21586214
[TBL] [Abstract][Full Text] [Related]
15. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of Hebrew version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0.
Ozeri D; Peretz S; Oppenheim A; Watad A; Lidar M; Braun-Moscovici Y
J Scleroderma Relat Disord; 2023 Feb; 8(1):31-35. PubMed ID: 36743811
[TBL] [Abstract][Full Text] [Related]
17. Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis.
Baron M; Hudson M; Steele R; Lo E;
J Rheumatol; 2011 Sep; 38(9):1925-30. PubMed ID: 21724704
[TBL] [Abstract][Full Text] [Related]
18. Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration.
Matsuda KM; Sugimoto E; Ako Y; Kitamura M; Miyahara M; Kotani H; Norimatsu Y; Hisamoto T; Kuzumi A; Fukasawa T; Sato S; Yoshizaki A
J Dermatol; 2024 Jun; 51(6):741-751. PubMed ID: 38558171
[TBL] [Abstract][Full Text] [Related]
19. Nutritional status and gastrointestinal symptoms in systemic sclerosis patients.
Murtaugh MA; Frech TM
Clin Nutr; 2013 Feb; 32(1):130-5. PubMed ID: 22770637
[TBL] [Abstract][Full Text] [Related]
20. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.
Khanna D; Hays RD; Park GS; Braun-Moscovici Y; Mayes MD; McNearney TA; Hsu V; Clements PJ; Furst DE
Arthritis Rheum; 2007 Oct; 57(7):1280-6. PubMed ID: 17907224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
